High Concentrations of Etanercept Reduce Human Islet Function and Integrity
Open Access
- 1 February 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 14, 599-610
Abstract
Background: Most islet transplant groups worldwide routinely use the TNFα inhibitor Etanercept in their peri-transplant protocols. Surprisingly, there have been no published dose-response studies on the effects of Etanercept on human islets. Our study aimed to address this by treating cultured human islets with increasing concentrations of Etanercept. Materials and Methods: Isolated human islets were cultured for 3– 4 days in normoxic (21% oxygen) or in hypoxic (2% oxygen) atmosphere using Etanercept dissolved in a range of 2.5– 40 μg/mL prior to islet characterisation. Results: In normoxic atmosphere, it was found that 5 μg/mL is the most efficient dose to preserve islet morphological and functional integrity during culture. Increasing the dose to 10 μg/mL or more resulted in detrimental effects with respect to viability and glucose-stimulated insulin release. When human islets were cultured for 3 to 4 days in clinically relevant hypoxia and treated with 5 μg/mL Etanercept, post-culture islet survival (P < 0.001) and in vitro function (P < 0.01) were significantly improved. This correlated with a substantially reduced cytokine production (P < 0.05), improved mitochondrial function (P < 0.01), and reduced production of reactive oxygen species (P < 0.001) in hypoxia-exposed islets. Conclusion: These findings suggest that the therapeutic window of Etanercept is very narrow and that this should be considered when optimising the dosage and route of Etanercept administration in islet-transplant recipients or when designing novel drug-delivering islet scaffolds.Keywords
This publication has 71 references indexed in Scilit:
- Analysis of Beta-Cell Gene Expression Reveals Inflammatory Signaling and Evidence of Dedifferentiation following Human Islet Isolation and CulturePLOS ONE, 2012
- Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapyArthritis Research & Therapy, 2011
- Mitochondrial reactive oxygen species drive proinflammatory cytokine productionJournal of Experimental Medicine, 2011
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Anti-Proinflammatory Effects of Sirolimus on Human Islet PreparationsTransplantation, 2008
- Gene Expression of Purified β-Cell Tissue Obtained from Human Pancreas with Laser Capture MicrodissectionThe Journal of Clinical Endocrinology & Metabolism, 2008
- Quantification of Basal and Stimulated ROS Levels as Predictors of Islet Potency and FunctionAmerican Journal of Transplantation, 2006
- Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic isletsClinical and Experimental Immunology, 2006
- Free radical-mediated oxidation of free amino acids and amino acid residues in proteinsAmino Acids, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001